Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
11.99
-0.81 (-6.33%)
At close: Sep 4, 2026, 4:00 PM EDT
12.07
+0.08 (0.65%)
After-hours: Sep 4, 2026, 7:54 PM EDT
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $356.94 million as of September 4, 2026. Its market cap has increased by 1,611.27% in one year.
Market Cap
356.94M
Enterprise Value
255.96M
1-Year Change
1,611.27%
Ranking
Category
Stock Price
$11.99
ChartMarket Cap Chart
Since March 26, 2024, Q32 Bio's market cap has increased from $199.19M to $356.94M, an increase of 79.20%. That is a compound annual growth rate of 26.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 356.94M | 773.76% |
| Dec 31, 2025 | 40.85M | -2.51% |
| Dec 31, 2024 | 41.90M | -78.96% |
| Mar 26, 2024 | 199.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 382.07M |
| Zentalis Pharmaceuticals | 377.74M |
| Agenus | 370.97M |
| Palisade Bio | 364.23M |
| DiaMedica Therapeutics | 364.00M |
| Lyell Immunopharma | 352.14M |
| Abeona Therapeutics | 343.10M |
| SAB Biotherapeutics | 338.47M |